CollPlant Biotechnologies (CLGN) EV to FCF (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly EV to FCF came in at 1.42 in Q4 2025, down 39.65% on a YoY basis from 2.36 in Q4 2024, and down 28.74% quarter-over-quarter from 2.0 in Q3 2025.
Analysis
CollPlant Biotechnologies (CLGN) EV to FCF (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has reported EV to FCF for 8 consecutive years, with 1.42 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, EV to FCF fell 39.65% year-over-year to 1.42; the trailing twelve-month figure through Dec 2025 stood at 0.36 (down 39.48% YoY), and the FY2025 full-year result was 0.44, down 25.0% from the prior year.
- EV to FCF slipped to 1.42 in Q4 2025 per CLGN's latest filing, from 2.0 in the prior quarter.
- Across five years, EV to FCF topped out at 26.33 in Q3 2022 and bottomed at 4.5 in Q4 2021.
- Historically, EV to FCF has averaged 6.05 across 5 years, with a median of 3.61 in 2024.
- The widest YoY moves for EV to FCF: up 5461.77% in 2021, down 503.74% in 2021.
- Over 5 years, EV to FCF stood at 4.5 in 2021, then soared by 136.39% to 1.64 in 2022, then jumped by 465.82% to 9.26 in 2023, then tumbled by 74.53% to 2.36 in 2024, then slumped by 39.65% to 1.42 in 2025.
- According to Business Quant data, EV to FCF over the past three periods registered 1.42, 2.0, and 4.16 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | CollPlant Biotechnologies | 4.17 Mn | 4.17 Mn | -243,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42 |
| Sep 30, 2025 | 2.00 |
| Jun 30, 2025 | 4.16 |
| Dec 31, 2024 | 2.36 |
| Sep 30, 2024 | 3.00 |
| Jun 30, 2024 | 3.61 |
| Mar 31, 2024 | 5.47 |
| Dec 31, 2023 | 9.26 |
| Sep 30, 2023 | -3.27 |
| Jun 30, 2023 | 3.89 |
| Mar 31, 2023 | 6.67 |
| Dec 31, 2022 | 1.64 |
| Sep 30, 2022 | 26.33 |
| Jun 30, 2022 | 21.86 |
| Mar 31, 2022 | 20.29 |
| Dec 31, 2021 | -4.50 |
| Sep 30, 2021 | 10.84 |
| Jun 30, 2021 | 0.93 |
| Mar 31, 2021 | -0.94 |
| Dec 31, 2020 | -0.99 |